Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCRX.L Regulatory News (CRX)

  • There is currently no data for CRX

Form 8.5 (EPT/RI) - Cyprotex Plc

27 Jun 2016 09:02

RNS Number : 3244C
Nplus1 Singer Capital Markets Ltd
27 June 2016
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Nplus1 Singer Capital Markets Limited

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

 

Cyprotex Plc

 

(c) Name of the party to the offer with which exempt principal trader is connected:

 

Cyprotex Plc

 

(d) Date dealing undertaken:

24 June 2016

 

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

No

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 1P

 

Purchase

 

5,628

 

101.55p

 

100.51p

 

ORD 1P

 

Sale

 

13,000

 

105p

 

101p

 

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

Date of disclosure:

27 June 2016

Contact name:

Reema Maru

Telephone number:

020 7496 3094

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERAKODPOBKKCAB
Date   Source Headline
1st Jun 20169:35 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
27th May 20165:04 pmRNSReplacement Form 8.3 - Cyprotex PLC
27th May 20164:59 pmRNSReplacement Form 8.3 - Cyprotex PLC
27th May 20164:56 pmRNSReplacement Form 8.3 - Cyprotex Plc
27th May 20164:45 pmRNSForm 8.3 - Cyprotex Plc - Replacement
27th May 20163:28 pmRNSForm 8.3 - Cyprotex
27th May 20168:59 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
25th May 20161:49 pmRNSForm 8.3 - Cyprotex PLC
24th May 201610:56 amRNSForm 8.3 - Cyprotex PLC
24th May 20168:54 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
23rd May 20169:42 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
19th May 20162:38 pmRNSNotice of AGM
19th May 201610:59 amBUSForm 8.3 - Cyprotex Plc
17th May 20167:00 amRNSLaunch of New Enhanced Version of chemPK
16th May 201610:10 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
13th May 20169:26 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
12th May 20169:37 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
11th May 20169:17 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
10th May 20169:38 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
10th May 20167:00 amRNSTrading Update
9th May 201611:35 amRNSUpdate Re General Meeting
9th May 201610:19 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
4th May 201610:08 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
3rd May 201610:35 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
29th Apr 201612:04 pmRNSForm 8.3 - Cyprotex
29th Apr 20169:38 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
28th Apr 20169:35 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
26th Apr 201611:24 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
26th Apr 20167:00 amRNSLaunch of GLP-Compliant Genotoxicity Services
25th Apr 201610:13 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
22nd Apr 20169:26 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
21st Apr 20164:53 pmRNSForm 8.3 - Cyprotex Plc
20th Apr 20164:37 pmRNSForm 8.3 - Cyprotex PLC
20th Apr 201610:05 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
18th Apr 201611:40 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
15th Apr 201610:08 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
14th Apr 201611:09 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
14th Apr 201610:10 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
13th Apr 201612:42 pmRNSReplacement Form 8.3 - Cyprotex plc
12th Apr 20161:57 pmRNSForm 8 (OPD) (Cyprotex PLC)
12th Apr 201612:18 pmRNSForm 8.3 - Cyprotex PLC
12th Apr 201611:18 amRNSForm 8.5 (EPT/RI)
12th Apr 201610:13 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
11th Apr 20165:46 pmRNSRule 2.10 Announcement
11th Apr 20163:39 pmRNSForm 8.5 (EPT/RI) - Cyprotex Plc
11th Apr 201611:05 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
8th Apr 20164:32 pmRNSRule 2.10 Announcement
8th Apr 201612:07 pmRNSForm 8.5 (EPT/RI) - Cyprotex Plc- Amendment
8th Apr 201611:05 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
7th Apr 20164:35 pmPRNForm 8.3 - Cyprotex Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.